Paid Clinical Trials Eugene
Discover 141 paid clinical trials in Eugene, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular HypertensionAGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
Sponsor:
AbbVie
Location:
Code:
NCT04499248
Conditions
Open-angle Glaucoma
Ocular Hypertension
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AGN-193408 SR
Lumigan
Sham Administration
Lumigan Vehicle
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Sponsor:
Karyopharm Therapeutics Inc
Location:
Code:
NCT05611931
Conditions
Endometrial Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Selinexor
Matching Placebo for selinexor
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLConsolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Sponsor:
Allogene Therapeutics
Location:
Code:
NCT06500273
Conditions
Large B-cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
cemacabtagene ansegedleucel
ALLO-647
Fludarabine
Cyclophosphamide
Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
Impact of Two Dietary Interventions on Simple Carbohydrate IntoleranceImpact of Two Dietary Interventions on Simple Carbohydrate Intolerance
Sponsor:
Oregon Health and Science University
Location:
Code:
NCT06057376
Conditions
Carbohydrate Intolerance
Eligibility Criteria
Sex: All
Age: 5 - 18
Healthy Volunteers: Not accepted
Interventions
Low-FODMAP diet group (LFD)
Low Sugar diet group (LAS)
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
Sponsor:
AstraZeneca
Location:
Code:
NCT06268873
Conditions
Chronic Kidney Disease and Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Baxdrostat/dapagliflozin
Dapagliflozin in combination with placebo
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial CancerStudy of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Sponsor:
Kartos Therapeutics, Inc.
Location:
Code:
NCT05797831
Conditions
Endometrial Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Navtemadlin
Navtemadlin Placebo
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Sponsor:
ReGenTree, LLC
Location:
Code:
NCT05555589
Conditions
Neurotrophic Keratopathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RGN-259
Placebo
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
Sponsor:
Sutro Biopharma, Inc.
Location:
Code:
NCT05870748
Conditions
Ovarian Cancer
Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Platinum-resistant Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Luveltamab tazevibulin
Pegfilgrastim
Gemcitabine
Paclitaxel
Pegylated liposomal doxorubicin
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor:
AstraZeneca
Location:
Code:
NCT06283966
Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
BGF MDI 320/14.4/9.6 μg
GFF MDI 14.4/9.6 μg
A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyA Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
Sponsor:
Boehringer Ingelheim
Location:
Code:
NCT06722157
Conditions
Macular Degeneration, Age-related
Geographic Atrophy
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
BI 771716
Pegcetacoplan
Sham comparator to BI 771716